Homologous boosting with adenoviral serotype 5 HIV vaccine (rAd5) vector can boost antibody responses despite preexisting vector-specific immunity in a randomized phase I clinical trial.
about
Vaccination with Replication Deficient Adenovectors Encoding YF-17D Antigens Induces Long-Lasting Protection from Severe Yellow Fever Virus Infection in MiceA Plasmodium Promiscuous T Cell Epitope Delivered within the Ad5 Hexon Protein Enhances the Protective Efficacy of a Protein Based Malaria VaccineHIV-1-Specific Antibody Response and Function after DNA Prime and Recombinant Adenovirus 5 Boost HIV Vaccine in HIV-Infected Subjects.Successive site translocating inoculation potentiates DNA/recombinant vaccinia vaccination
P2860
Homologous boosting with adenoviral serotype 5 HIV vaccine (rAd5) vector can boost antibody responses despite preexisting vector-specific immunity in a randomized phase I clinical trial.
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Homologous boosting with adeno ...... omized phase I clinical trial.
@ast
Homologous boosting with adeno ...... omized phase I clinical trial.
@en
Homologous boosting with adenoviral serotype 5 HIV vaccine
@nl
type
label
Homologous boosting with adeno ...... omized phase I clinical trial.
@ast
Homologous boosting with adeno ...... omized phase I clinical trial.
@en
Homologous boosting with adenoviral serotype 5 HIV vaccine
@nl
prefLabel
Homologous boosting with adeno ...... omized phase I clinical trial.
@ast
Homologous boosting with adeno ...... omized phase I clinical trial.
@en
Homologous boosting with adenoviral serotype 5 HIV vaccine
@nl
P2093
P2860
P50
P1433
P1476
Homologous boosting with adeno ...... omized phase I clinical trial.
@en
P2093
Adrian B McDermott
Laura Novik
Mario Roederer
Martha C Nason
Mary E Enama
Richard A Koup
Robert T Bailer
Sarah A Plummer
Uzma N Sarwar
VRC 015 study team
P2860
P304
P356
10.1371/JOURNAL.PONE.0106240
P407
P577
2014-09-29T00:00:00Z